Sunlight and reduced risk of cancer: Is the real story vitamin D?

Journal of the National Cancer Institute

Volumn 97, Issue 3, 2005, Pages 161-163

  Egan, Kathleen M ^a   Sosman, Jeffrey A ^a   Blot, William J ^a,b  

^a VANDERBILT INGRAM CANCER CENTER   (United States)

^b INTERNATIONAL EPIDEMIOLOGY INSTITUTE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

B RAF KINASE; CALCITRIOL; SUNSCREEN; VITAMIN D; VITAMIN D RECEPTOR;

CANCER CELL CULTURE; CANCER INCIDENCE; CANCER MORTALITY; CANCER RISK; CANCER STAGING; CANCER SURVIVAL; CANCER SUSCEPTIBILITY; CARCINOGENESIS; CELL CYCLE G1 PHASE; CELL CYCLE S PHASE; CELL DIFFERENTIATION; CELL PROLIFERATION; DENMARK; DIET SUPPLEMENTATION; DISEASE ASSOCIATION; EDITORIAL; ELASTOSIS; FAMILY HISTORY; FOLLOW UP; FOOD INTAKE; GENE MUTATION; HUMAN; IMMUNE DEFICIENCY; INHIBITION KINETICS; MELANOMA; MITOSIS INHIBITION; NONHODGKIN LYMPHOMA; NUTRITIONAL HEALTH; OUTCOMES RESEARCH; POPULATION RESEARCH; PRIORITY JOURNAL; PROGNOSIS; PROTEIN EXPRESSION; PUBLIC HEALTH SERVICE; RISK BENEFIT ANALYSIS; RISK FACTOR; RISK REDUCTION; SAFETY; SKIN CANCER; SOLAR RADIATION; SUN EXPOSURE; SUNBURN; SUNLIGHT; SWEDEN; ULTRAVIOLET B RADIATION; VITAMIN D DEFICIENCY; BIOSYNTHESIS; CASE CONTROL STUDY; EPIDEMIOLOGY; INCIDENCE; METABOLISM; MORTALITY; NEOPLASM; NOTE; RISK ASSESSMENT; SKIN TUMOR; SURVIVAL RATE; ULTRAVIOLET RADIATION; UNITED STATES;

CALCITRIOL; CASE-CONTROL STUDIES; CONFOUNDING FACTORS (EPIDEMIOLOGY); DENMARK; HUMANS; INCIDENCE; LYMPHOMA, NON-HODGKIN; MELANOMA; NEOPLASMS; RISK ASSESSMENT; SKIN NEOPLASMS; SUNLIGHT; SURVIVAL RATE; SWEDEN; ULTRAVIOLET RAYS; UNITED STATES; VITAMIN D;

EID: 13744255127     PISSN: 00278874     EISSN: None     Source Type: Journal    
DOI: 10.1093/jnci/dji047     Document Type: Editorial

References (28)

1. Nyugen TH, Ho DQ. Nonmelanoma skin cancer. Curr Treat Options Oncol 2002;3:193-203.
2. Smedby KE, Hjalgrim H, Melbye M, Torrång A, Rostgaard K, Munksgaard L, et al. Ultraviolet radiation exposure and risk of malignant lymphomas. J Natl Cancer Inst 2005;97:199-209.
3. Berwick M, Armstrong BK, Ben-Porat L, Fine J, Kricker A, Eberle C, Barnhill R. Sun exposure and mortality from melanoma. J Natl Cancer Inst 2005;97:195-9.
4. Devesa SS, Grauman MA, Blot, WJ, Pennello GA, Hoover RN, Fraumeni JF. Atlas of cancer mortality in the United States: 1950 to 1994. NIH Publication No. 99-4564, 1999.
5. Blot WJ, McLaughlin JK. Geographic patterns of breast cancer among American women. J Natl Cancer Inst 1995;87:1819-20.
6. Grant WB. Ecologic studies of solar UV-B radiation and cancer mortality rates. Recent Results Cancer Res 2003;164:371-7.
7. Garland FC, Garland CF, Gorham ED, Young JF. Geographic variation in breast cancer mortality in the United States: a hypothesis involving exposure to solar radiation. Prev Med 1990;19:614-22.
8. Kawa S, Nikaido T, Aoki Y, et al. Vitamin D analogues up-regulate p21 and p27 during growth inhibition of pancreatic cancer cell lines. Br J Cancer 1997;76:884-9.
9. Verlinden L, Verstuyf A, Convents R, et al. Action of 1,25 (OH)2 D3 on the cell cycle genes, cyclin D1, 21 and p27 in MCF)7 cells. Mol Cell Endocrinol 1998;142:57-65.
10. Liu M, Lee MH, Cohen M, et al. Transcriptional activation of the Cdk inhibitor p21 by vitamin D3 leads to the induced differentiation of the myelomonocytic cell line U937. Genes Dev 1996;10:142-53.
11. Tangpricha V, Pearce EN, Chen TC, Holick MF. Vitamin D insufficiency among free-living healthy young adults. Am J Med 2002;112:659-62.
12. Colston K, Colston MJ, Feldman D. 1,25-Dihydroxyvitamin D3 and malignant melanoma: the presence of receptors and inhibition of cell growth in culture. Endocrinology 1981;108:1083-6.
13. Hutchinson PE, Osborne JE, Lear JT, et al. Vitamin D receptor polymorphisms are associated with altered prognosis in patients with malignant melanoma. Clin Cancer Res 2000;2:498-504.
14. Green A, Siskind V. Geographical distribution of cutaneous melanoma in Queensland. Med J Aust 1983;1:407-10.
15. Elwood JM, Gallagher RP, Hill GB, Pearson JC. Cutaneous melanoma in relation to intermittent and constant sun exposure - the Western Canada Melanoma Study. Int J Cancer 1985;35:427-33.
16. Dennis LK, Beane Freeman LE, VanBeek MJ. Sunscreen use and the risk for melanoma: a quantitative review. Ann Intern Med 2003;139:966-78.
17. Matsuoka LY, Ide L, Wortsman J, MacLaughlin JA, Holick MF. Sunscreens suppress cutaneous vitamin D3 synthesis. J Clin Endocrinol Metab 1987;64:1165-8.
18. Dicker TJ, Kavanagh GM, Herd RM, Ahmad T, McLaren KM, Chetty U, Hunter JA. A rational approach to melanoma follow-up in patients with primary cutaneous melanoma. Scottish Melanoma Group. Br J Dermatol 1999;140:249-54.
19. Rivers JK. Is there more than one road to melanoma? Lancet 2004;363:728-30.
20. Maldonado JL, Fridlyand J, Patel H, Jain AN, Busam K, Kageshita T, et al. Determinants of BRAF mutations in primary melanomas. J Natl Cancer Inst 2003;95:1878-90.
21. Edwards RH, Ward MR, Wu H, Medina CA, Brose MS, Volpe P, et al. Absence of BRAF mutations in UV-protected mucosal melanomas. J Med Genet 2004;41:270-2.
22. Cruz F 3rd, Rubin BP, Wilson D, Town A, Schroeder A, Haley A, et al. Absence of BRAF and NRAS mutations in uveal melanoma. Cancer Res 2003;63:5761-6.
23. Rimoldi D, Salvi S, Lienard D, Lejeune FJ, Speiser D, Zografos L, Cerottini JC. Lack of BRAF mutations in uveal melanoma. Cancer Res 2003;63: 5712-5.
24. Doll R, Fraumeni JF Jr, Muir CS. Trends in cancer incidence and mortality. Cancer Surveys, Vol 19/20, Cold Spring Harbor Lab Press, 1994.
25. Donawho CK, Muller HK, Bucana CD, Kripke ML. Enhanced growth of murine melanoma in ultraviolet-irradiated skin is associated with local inhibition of immune effector mechanisms. J Immunol 1996;157: 781-6.
26. Hughes AM, Armstrong BK, Vajdic CM, Turner J, Grulich AE, Fritschi L, et al. Sun exposure may protect against non-Hodgkin lymphoma: a case-control study. Int J Cancer 2004;112:865-71.
27. Jemal A, Tiwari RC, Murray T, Ghafoor A, Samuels A, Ward E, et al. American Cancer Society. Cancer statistics, 2004. CA Cancer J Clin 2004;54:8-29.
28. Webb AR, Kline L, Holick MF. Influence of season and latitude on the cutaneous synthesis of vitamin D3: exposure to winter sunlight in Boston and Edmonton will not promote vitamin D3 synthesis in human skin. J Clin Endocrinol Metab 1988;67:373-8.